Maes M, Meltzer H Y, Cosyns P, Suy E, Schotte C
Department of Psychiatry, University Hospitals of Cleveland, OH 44106.
Psychoneuroendocrinology. 1993;18(8):607-20. doi: 10.1016/0306-4530(93)90037-l.
In order to evaluate the function of the hypothalamic-pituitary-thyroid (HPT)-axis in unipolar depression, the authors measured basal 0800h plasma levels of free thyroxine (FT4), free triiodothyronine (FT3), and thyroid stimulating hormone (TSH) by means of the new, ultrasensitive assays (TSH-IRMA) in 69 healthy controls, 62 minor, 101 simple major, and 57 melancholic depressed subjects. Basal HPT-axis hormone levels of almost all (96.8%) unipolar depressed patients fell within the normal, euthyroid range. None of the major depressed subjects showed subclinical hypothyroidism. It was found that 8.8% of the melancholic subjects exhibited some degree of subclinical hyperthyroidism. Basal TSH-IRMA values were significantly lower in melancholic patients than in healthy controls, minor and simple major depressed patients, and in major vs. minor depressed subjects. FT4 circulating levels were significantly higher in melancholic patients than in all other subjects. Basal TSH-IRMA and FT4 levels were significantly correlated with severity of illness. In depression, there was a significant and negative correlation between basal TSH-IRMA values and FT4 concentrations. No significant gender- or age-related differences in TSH-IRMA or thyroid hormones were detected in depression. It is argued that--in depression research--the assays of basal TSH-IRMA should replace thyrotropin releasing hormone tests.
为了评估下丘脑 - 垂体 - 甲状腺(HPT)轴在单相抑郁症中的功能,作者采用新的超灵敏检测方法(促甲状腺激素免疫放射测定法,TSH - IRMA),对69名健康对照者、62名轻度抑郁症患者、101名单纯重度抑郁症患者和57名抑郁性抑郁症患者进行了上午8点的基础血浆游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)和促甲状腺激素(TSH)水平的测量。几乎所有(96.8%)单相抑郁症患者的基础HPT轴激素水平都在正常甲状腺功能范围内。重度抑郁症患者中无一例表现为亚临床甲状腺功能减退。研究发现,8.8%的抑郁性抑郁症患者存在一定程度的亚临床甲状腺功能亢进。抑郁性抑郁症患者的基础TSH - IRMA值显著低于健康对照者、轻度和单纯重度抑郁症患者,以及重度与轻度抑郁症患者之间的比较。抑郁性抑郁症患者的FT4循环水平显著高于所有其他受试者。基础TSH - IRMA和FT4水平与疾病严重程度显著相关。在抑郁症中,基础TSH - IRMA值与FT4浓度之间存在显著负相关。在抑郁症患者中,未检测到TSH - IRMA或甲状腺激素存在显著的性别或年龄差异。有人认为,在抑郁症研究中,基础TSH - IRMA检测应取代促甲状腺激素释放激素试验。